MetLife Inc expected to post earnings of $2.29 a share - Earnings Preview
MetLife Inc expected to post earnings of $2.29 a share - Earnings Preview
MetLife Inc MET.N, MET is expected to show a rise in quarterly revenue when it reports results on August 5 for the period ending June 30 2026
The New York City-based company is expected to report a 10.0% increase in revenue to $19.709 billion from $17.92 billion a year ago, according to the mean estimate from 7 analysts, based on LSEG data. (Sales/ Revenue Majority Basis is on Total Adjusted Revenues)
LSEG's mean analyst estimate for MetLife Inc is for earnings of $2.29 per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 14 "strong buy" or "buy," 6 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for MetLife Inc is $98.50, about 2.3% above its last closing price of $96.31
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Mar. 31 2026 | 2.27 | 2.27 | 2.42 | Beat | 6.5 |
Dec. 31 2026 | 2.33 | 2.34 | 2.58 | Beat | 10.2 |
Sep. 30 2025 | 2.31 | 2.32 | 2.37 | Beat | 2.2 |
Jun. 30 2025 | 2.14 | 2.15 | 2.02 | Missed | -5.9 |
Mar. 31 2025 | 1.99 | 2.00 | 1.96 | Missed | -1.9 |
Dec. 31 2024 | 2.09 | 2.10 | 2.08 | Missed | -0.8 |
Sep. 30 2024 | 2.19 | 2.17 | 1.95 | Missed | -10.1 |
Jun. 30 2024 | 2.09 | 2.10 | 2.28 | Beat | 8.4 |
This summary was machine generated August 3 at 23:28 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Recent news on MetLife
See all newsMedia: Prudential Mexico, Brazil units draw interest from MetLife, CNP - Bloomberg News
US RESEARCH ROUNDUP-Danaher Corporation, Illumina, Reliance
Brief: Metlife Full-Year 2026 Guidance For Variable Investment Income About $1.60 Billion Pre-Tax
U.S. RESEARCH ROUNDUP-Accendra Health, Celestica, Sionna Therapeutics
MetLife, Inc. reports results for the quarter ended June 30 - Earnings Summary